TOI
The Oncology·NASDAQ
--
--(--)
--
--(--)
9.16 / 10
Outperform
Analyst coverage is overwhelmingly bullish, with four Strong Buy ratings and a 9.16 sentiment score. Fund flow is good (7.27) but trends are negative across size segments, inflow ratios around 0.44‑0.48. The analyst view dominates, supporting a positive bias.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-09
InstitutionBTIG
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for TOI?
- TOI holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 9.16/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
